Medirom Return on Average Assets from 2010 to 2024
| MRM Stock | USD 6.06 0.02 0.33% |
Check Medirom Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medirom main balance sheet or income statement drivers, such as Tax Provision of 33.7 M, Interest Income of 7.3 M or Depreciation And Amortization of 182.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0 or Days Sales Outstanding of 155. Medirom financial statements analysis is a perfect complement when working with Medirom Healthcare Valuation or Volatility modules.
Medirom | Return on Average Assets |
About Medirom Healthcare Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Medirom Healthcare income statement, its balance sheet, and the statement of cash flows. Medirom Healthcare investors use historical funamental indicators, such as Medirom Healthcare's Return on Average Assets, to determine how well the company is positioned to perform in the future. Although Medirom Healthcare investors may use each financial statement separately, they are all related. The changes in Medirom Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medirom Healthcare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Medirom Healthcare Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Medirom Healthcare. Please read more on our technical analysis and fundamental analysis pages.
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 171 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medirom Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medirom Healthcare's short interest history, or implied volatility extrapolated from Medirom Healthcare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Medirom Healthcare Correlation against competitors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Medirom Stock analysis
When running Medirom Healthcare's price analysis, check to measure Medirom Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medirom Healthcare is operating at the current time. Most of Medirom Healthcare's value examination focuses on studying past and present price action to predict the probability of Medirom Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medirom Healthcare's price. Additionally, you may evaluate how the addition of Medirom Healthcare to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Medirom Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.05) | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.03 | Return On Assets (0.01) | Return On Equity (7.00) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.